THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP AN ORAL AGENT FOR RED BLOOD CELL PREPARATION IN THE ISOTOPIC LABELING OF THE BLOOD POOL.

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 4991
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1986
Solitcitation Year: N/A
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
Nuclear Diagnostic
2040 South Broadway Avenue, Springfield, MO, 65807
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MICHAEL H DAVIS
 PRINCIPAL INVESTIGATOR
 (417) 881-1100
Business Contact
Phone: () -
Research Institution
N/A
Abstract
THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP AN ORAL AGENT FOR RED BLOOD CELL PREPARATION IN THE ISOTOPIC LABELING OF THE BLOOD POOL. THIS AGENT WILL SHORTEN TECHNICIAN TIME, REDUCE RADIATION EXPOSURE, AND IMPROVE NUCLEAR IMAGING AND PATIENT ACCEPTANCE. THIS STUDY IS DESIGNED TO DEMONSTRATE THE SAFETY AND EFFICACY OF THE PROCEDURE AS WELL AS TO INITIATE STABILITY TESTING OF THE COMPOUND. THIS SUBSTANCE WILL BE ADMINISTERED ORALLY PRIOR TO THE INTRAVENOUS ADMINISTRATION OF TECHNETIUM PERTECHNETATE.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government